Summary
RMC No. 25-2025 publishes the full text of the February 24, 2025 letter from FDA Director General Samuel A. Zacate endorsing updates to the List of VAT-Exempt Products under RA No. 10963 (TRAIN Law) and RA No. 11534 (CREATE Act).
Key points
- Updated list. The list now includes certain medicines for diabetes, hypertension, high cholesterol and mental illness.
- Effectivity of exemption. As clarified under Q&A No. 1 of RMC No. 99-2021, the VAT exemption of covered medicines and medical devices under the CREATE Act takes effect on the date the FDA publishes the list updates.
Who is affected
- Sellers and buyers of covered medicines and medical devices
Deadlines and effectivity
- FDA letter dated February 24, 2025
- Exemption effective on date of FDA publication of the updates
Summary by Tax Resources PH. It is not a substitute for the full text of the issuance or professional advice.
Copies of BIR issuances are hosted here for reference. For the official version, check bir.gov.ph. Summaries by Tax Resources PH are not a substitute for the full text or professional advice.